GSK2018682

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting

Phase 1

GSK2018682 FTIH in Healthy Volunteers

CompletedNCT01387217

GlaxoSmithKlineMultiple Sclerosis

Start: 2010-05-21End: 2010-12-20Updated: 2017-06-09

Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

CompletedNCT01431937

GlaxoSmithKlineMultiple Sclerosis, Relapsing-Remitting

Start: 2010-10-10End: 2011-03-29Updated: 2017-07-07